Related Experiment Videos
Cerebrovascular accidents in acute myocardial infarction
Insights
Cerebral ischemia occurred in 1.9% of myocardial infarction patients, often affecting the carotid artery and worsening prognosis. Standard anticoagulant therapy did not prevent these serious neurological complications.
Area of Science:
- Cardiology
- Neurology
- Vascular Medicine
Background:
- Myocardial infarction (MI) patients face risks beyond cardiac events.
- Cerebral ischemia is a significant concern in post-MI patients.
- Understanding the incidence and characteristics of cerebral ischemia in MI is crucial.
Purpose of the Study:
- To determine the incidence of cerebral ischemia in patients with myocardial infarction.
- To describe the clinical presentation and affected vascular systems.
- To evaluate the effectiveness of anticoagulant prophylaxis in preventing these events.
Main Methods:
- Retrospective analysis of 1277 patients with myocardial infarction.
- Recording of cerebral ischemia events, particularly those involving the carotid artery system.
- Review of patient demographics, clinical outcomes, and prophylactic anticoagulant regimens.
Main Results:
- Cerebral ischemia was observed in 1.9% of MI patients.
- Ischemia predominantly affected the carotid artery system, leading to hemiparesis or hemiplegia.
- Elderly patients with MI and cerebral ischemia had a poorer prognosis.
- Subcutaneous calcium heparin prophylaxis did not appear to prevent these complications.
Conclusions:
- Cerebral ischemia is a notable complication in myocardial infarction patients, frequently impacting the carotid artery system.
- While embolic events are likely contributors, other pathogenetic mechanisms warrant investigation.
- Current prophylactic anticoagulant strategies, as administered, may be insufficient to mitigate the risk of cerebral ischemia in this population.
Abstract:
Cerebral ischemia was recorded in 1.9% of 1277 patients with myocardial infarction. In most cases ischemia involved the carotid artery system, usually causing a hemiparesis or hemiplegia. Patients were mostly elderly, and the ischemic episode worsened their prognosis. The pathogenesis was surely often of embolic origin but several facts suggest that other mechanisms were also involved. Anticoagulant therapy, at least in the form in which it was used in these patients, i.e. subcutaneous administration of calcium heparin 5000 I.U. b.i.d. for thrombophlebitis prophylaxis, does not seem to prevent these complications.